Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Nomura Holdings ( (NMR) ) is now available.
On May 15, 2025, Nomura Holdings announced a decision by its Executive Management Board to dispose of treasury shares as a stock award. This move involves granting Restricted Stock Units (RSUs) and Performance Share Units (PSUs) to directors, executive officers, and employees as deferred compensation. The RSU and PSU plans are designed to align the interests of the company’s leadership and employees with its performance targets, potentially impacting the company’s operational dynamics and stakeholder relationships by incentivizing performance and retention.
Spark’s Take on NMR Stock
According to Spark, TipRanks’ AI Analyst, NMR is a Neutral.
Nomura Holdings demonstrates strong growth and operational efficiency with a robust revenue increase and high EBIT margin. However, financial risks from high leverage and negative cash flow, coupled with technical indicators showing potential bearish trends, balance the positive valuation metrics and strategic initiatives from the earnings call. The stock’s low P/E ratio and healthy dividend yield make it attractive for value investors, but caution is advised due to financial and market volatility.
To see Spark’s full report on NMR stock, click here.
More about Nomura Holdings
Nomura Holdings, Inc. is a prominent financial services group headquartered in Tokyo, Japan. It operates in the securities and investment banking industry, providing a wide range of services including asset management, retail brokerage, and investment banking solutions. The company focuses on both domestic and international markets, catering to a diverse clientele ranging from individual investors to large corporations.
Average Trading Volume: 837,845
Technical Sentiment Signal: Buy
Current Market Cap: $18.02B
For detailed information about NMR stock, go to TipRanks’ Stock Analysis page.